FDA Clearance Tracker · P850048-S002
TANDEM-R PSA IMMUNORADIOMETRIC ASSAY
Last checked: Nov 20, 2026Latest source record: Jul 10, 1987 (this decision)Source: openFDAMethods & limitations
Decided
Jul 10, 1987
Approved
Time to decision
136 days
Received Feb 24, 1987. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P850048-S002
- Device name
- TANDEM-R PSA IMMUNORADIOMETRIC ASSAY
- Applicant
- Beckman Coulter, Inc.
- Applicant location
- Brea, CA
- Received
- Feb 24, 1987
- Decided
- Jul 10, 1987
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P850048
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.6010
- Specialty
- Laboratory Medicine & Pathology
Source documents
Other decisions for Beckman Coulter, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Access BNP II510(k)
K262597 · Decided Oct 20, 2026 · 85 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.